/3183.T
3183.T Stock - WIN-Partners Co., Ltd.
Healthcare|Medical - DistributionJPX
$1387.00+0.65%
+$9.00 (+0.65%) • Jan 16
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.68
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1525.70
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 3183.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1373.13 – $1400.87
TARGET (TP)$1595.05
STOP LOSS$1276.04
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.12
52W High$1595.00
52W Low$1125.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $81.41B | $77.06B | $70.85B | $66.39B | $62.12B |
| Gross Profit | $9.89B | $9.53B | $8.66B | $8.52B | $7.74B |
| Gross Margin | 12.2% | 12.4% | 12.2% | 12.8% | 12.5% |
| Operating Income | $2.81B | $2.63B | $2.47B | $2.76B | $2.26B |
| Net Income | $2.02B | $1.84B | $2.05B | $1.83B | $1.54B |
| Net Margin | 2.5% | 2.4% | 2.9% | 2.8% | 2.5% |
| EPS | $70.45 | $64.40 | $72.04 | $63.88 | $53.66 |
Company Overview
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring and magnetic resonance imaging equipment. The company was founded in 1973 and is headquartered in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
3183.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$19.15
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | — | — | — | — |
Q4 2025 | Nov 5, 2025 | — | $19.15 | — | — |
Q3 2025 | Aug 5, 2025 | — | $16.98 | — | — |
Q2 2025 | May 12, 2025 | — | $21.14 | — | — |
Q1 2025 | Feb 5, 2025 | — | $19.63 | — | — |
Q4 2024 | Nov 5, 2024 | — | $15.74 | — | — |
Q3 2024 | Aug 5, 2024 | — | $13.89 | — | — |
Q2 2024 | May 14, 2024 | — | $22.31 | — | — |
Q1 2024 | Feb 7, 2024 | — | $17.35 | — | — |
Q4 2023 | Nov 8, 2023 | — | $14.48 | — | — |
Q3 2023 | Aug 7, 2023 | — | $10.23 | — | — |
Q2 2023 | May 12, 2023 | — | $17.45 | — | — |
Q1 2023 | Feb 7, 2023 | — | $28.50 | — | — |
Q4 2022 | Nov 8, 2022 | — | $11.74 | — | — |
Q3 2022 | Aug 5, 2022 | — | $14.11 | — | — |
Q2 2022 | May 13, 2022 | — | $12.94 | — | — |
Q1 2022 | Feb 10, 2022 | — | $23.07 | — | — |
Q4 2021 | Nov 10, 2021 | — | $15.14 | — | — |
Q3 2021 | Aug 11, 2021 | — | $12.72 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 3183.T
What is 3183.T's current stock price?
WIN-Partners Co., Ltd. (3183.T) is currently trading at $1387.00 per share. The stock has moved +0.65% today.
What is the analyst price target for 3183.T?
No analyst price targets are currently available for this stock.
What sector is WIN-Partners Co., Ltd. in?
WIN-Partners Co., Ltd. operates in the Healthcare sector, specifically within the Medical - Distribution industry. The company is traded on the JPX exchange.
What is 3183.T's market cap?
WIN-Partners Co., Ltd. has a market capitalization of $38.53 billion, making it a large-cap company.
Does 3183.T pay dividends?
No, WIN-Partners Co., Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector4548.T
Seikagaku Corporation
$721.00
Mkt Cap: $39.4B
4577.T
Daito Pharmaceutical Co.,Ltd.
$1360.00
Mkt Cap: $40.2B
5592.T
Kusurinomadoguchi, Inc.
$2859.00
Mkt Cap: $32.1B
6062.T
Charm Care Corporation
$1310.00
Mkt Cap: $42.8B
6823.T
Rion Co., Ltd.
$2853.00
Mkt Cap: $35.2B
7679.T
YAKUODO HOLDINGS Co., Ltd.
$2072.00
Mkt Cap: $40.3B
7749.T
Medikit Co.,Ltd.
$2985.00
Mkt Cap: $43.7B
7777.T
3-D Matrix, Ltd.
$480.00
Mkt Cap: $53.1B
9158.T
CUC Inc.
$878.00
Mkt Cap: $25.7B
9273.T
Koa Shoji Holdings Co.,Ltd.
$883.00
Mkt Cap: $37.2B
Explore stocks similar to 3183.T for comparison